Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

196.77 -2.17 (-1.09%)
Streaming Delayed Price Updated: 10:10 AM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
28 29 Next >
News headline image
US Judge Weighs Nationwide Ban On Abortion Pills ↗
U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is... 
Via Benzinga
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well ↗
The Federal Deposit Insurance Corporation (FDIC) closed Silicon Valley Bank, the banking arm of SVB Financial Group (NASDAQ: 
Via Benzinga
News headline image
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs ↗
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per... 
Via Benzinga
News headline image
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities ↗
 
Via Benzinga
News headline image
Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births ↗
 
Via Benzinga
News headline image
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗
 
Via Benzinga
News headline image
Retail And Regional Banks Will Call The Shots ↗
The 23-month moving average or a 2-year business cycle is particularly important this year after a big up then down year-looms large. 
Via Talk Markets
News headline image
The Economic Modern Family Ready To Howl? ↗
As we ended the trading week, there were a few other “worms” that appeared in the market soil. They too seemed to awaken from hibernation as the indices’ prices rose. Are the components of the Economic... 
Via Talk Markets
News headline image
Bullish Reversals ↗
Agricultural commodities have fallen a lot lately. Food supply and shortages remain a concern going into the spring and summer growing seasons. 
Via Talk Markets
News headline image
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗
 
Via Benzinga
News headline image
Century Aluminum Pops Up As Bullish ↗
Given the recent sell-off in aluminum, copper, and steel, industrial metals remain overall outperformers. 
Via Talk Markets
News headline image
Stock Market Forecast: Stocks May Drop Further As Rates Rise ↗
This week will be full of economic insights, but the big data will be the ISM manufacturing and services indexes. However, I think these two reports are unlikely to do much to reverse the current trend... 
Via Talk Markets
News headline image
No Landing - Sugar Coated Words For Stagflation? ↗
SPX failed the 23-month moving average or 2-year business cycle, which if clears, signals a softer landing. Yet, it held the pivotal 3900 ahead of the Fed, signaling a no landing. 
Via Talk Markets
News headline image
Is The Whole Country Buying Teslas And Eating At Wingstop? ↗
XRT is making lower highs each of the last 3 weeks but also has found a basis of support at 68.00. 
Via Talk Markets
News headline image
Tuesday Talk: My Sweet CPI ↗
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday. 
Via Talk Markets
News headline image
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers ↗
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends. 
Via Talk Markets
News headline image
ARK Invest: The 7 Words That Explain Why Wall Street Can’t Stand Cathie Wood ↗
Why does Wall Street hate Cathie Wood and her ARKK ETF? Seven words show how her focus on innovation divides investors. 
Via InvestorPlace
News headline image
2-Year Business Cycles Matter In Commodities ↗
Gold is above the 23-month MA and the 2-year business cycle. 
Via Talk Markets
News headline image
2-Year Business Cycles Matter In This Market ↗
In October, IWM held the 80-month and got us believing that a recession would be averted. Now, the market literally hangs in the balance between a longer-term and a shorter-term business cycle. 
Via Talk Markets
News headline image
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
News headline image
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More ↗
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new... 
Via Benzinga
News headline image
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January ↗
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%. 
Via Talk Markets
News headline image
What Are The Equities Market’s Warning Signs? ↗
The 52-week New High / New Low ratio for the Nasdaq Composite has actually begun to deteriorate, a clear Risk-Off indication for the short term. 
Via Talk Markets
News headline image
Inflation, What Inflation? ↗
We typically have a song or two in our heads. After all, watching ticks is musical and has a lot of different beats. And typically, those songs turn into parodies. 
Via Talk Markets
News headline image
Global Stocks: Breaking Out? ↗
The S&P 500 is attempting to clear what has been an insurmountable trendline dating back to January 2022. 
Via Talk Markets
News headline image
The 3 Best Biotech Stocks Under $1 to Buy for January ↗
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich. 
Via InvestorPlace
News headline image
Longeveron Shares Surge Following FDA Decision on Biogen Alzheimer's Drug ↗
Shares of Longeveron (NASDAQ: LGVN) are trading 5.37% higher amid strength in Alzheimer's-related stocks after the FDA granted accelerated approval to Biogen (NASDAQ: BIIB)'s Leqembi.  
Via Benzinga
News headline image
SAVA, LLY, IBB: Why These Alzheimer's Related Stocks Are Volatile On Friday ↗
Stocks of companies with Alzheimer's candidates, including Cassava Sciences, Inc. (NASDAQ: SAVA) and Eli Lilly And Company (NYSE: LLY), spiked on Friday after the FDA granted accelerated approval to 
Via Benzinga
News headline image
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗
Biopharma stocks were not immune to the broader market downturn seen for much of 2022. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.